Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

about

Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system.

P2860

Q38737582-BF163BB2-6704-4743-AD25-5104C548FDF7 Q47549087-72DB4F23-63A0-4D04-9DFE-58C9105AEDD5

P2860

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

Item

http://www.wikidata.org/entity/Q26775082

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@ast

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@en

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@nl

type

Item

label

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@ast

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@en

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@nl

prefLabel

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@ast

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@en

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@nl

P1476

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

@en

P2093

Chongbo Zhao

http://www.w3.org/2001/XMLSchema#string

Xiaojian Yao

http://www.w3.org/2001/XMLSchema#string

Zhujun Ao

http://www.w3.org/2001/XMLSchema#string

P2860

Few and far between: how HIV may be evading antibody avidity

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

Dendritic cell-based immunity and vaccination against hepatitis C virus infection

Virus Like Particles as Immunogens and Universal Nanocarriers

Antibody responses to envelope glycoproteins in HIV-1 infection

Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models

Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/VACCINES4010002

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291526224

http://www.w3.org/2001/XMLSchema#string

P698

26805898

http://www.w3.org/2001/XMLSchema#string

P921

virology

P932

4810054

http://www.w3.org/2001/XMLSchema#string

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

about

P2860

P2860

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932